XML 77 R6.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Balances at Dec. 31, 2016 $ 62,966 $ 1 $ 108,246 $ (45,277) $ (4)
Balances (in shares) at Dec. 31, 2016   13,431,000      
Issuance of common stock in connection with employee stock purchase plan 131   131    
Issuance of common stock in connection with employee stock purchase plan (in shares)   39,000      
Issuance of common stock in connection with exercise of stock options 702   702    
Issuance of common stock in connection with exercise of stock options (in shares)   200,000      
Issuance of common stock in connection with initial public offering/ follow-on offering/ at-the-market offerings, net of offering costs 11,380 $ 1 11,379    
Issuance of common stock in connection with initial public offering/ follow-on offering at-the-market offerings, net of offering costs (in shares)   3,000,000      
Stock-based compensation expense 2,492   2,492    
Unrealized gain (loss) on marketable securities (98)       (98)
Net loss (27,236)     (27,236)  
Balances at Dec. 31, 2017 50,337 $ 2 122,950 (72,513) (102)
Balances (in shares) at Dec. 31, 2017   16,670,000      
Issuance of common stock in connection with employee stock purchase plan 207   207    
Issuance of common stock in connection with employee stock purchase plan (in shares)   56,000      
Issuance of common stock in connection with exercise of stock options 2,829   2,829    
Issuance of common stock in connection with exercise of stock options (in shares)   521,000      
Issuance of common stock in connection with initial public offering/ follow-on offering/ at-the-market offerings, net of offering costs 54,048   54,048    
Issuance of common stock in connection with initial public offering/ follow-on offering at-the-market offerings, net of offering costs (in shares)   6,893,000      
Stock-based compensation expense 4,280   4,280    
Unrealized gain (loss) on marketable securities 75       75
Net loss (44,348)     (44,348)  
Balances at Dec. 31, 2018 67,428 $ 2 184,314 (116,861) (27)
Balances (in shares) at Dec. 31, 2018   24,140,000      
Issuance of common stock in connection with employee stock purchase plan 307   307    
Issuance of common stock in connection with employee stock purchase plan (in shares)   45,000      
Issuance of common stock in connection with exercise of stock options $ 1,143   1,143    
Issuance of common stock in connection with exercise of stock options (in shares) 274,436 274,000      
Issuance of common stock and pre-funded warrants in connection with public offering, net of offering costs $ 64,503 $ 1 64,502    
Issuance of common stock and pre-funded warrants in connection with public offering, net of offering costs (in shares)   4,625,000      
Stock-based compensation expense 4,876   4,876    
Unrealized gain (loss) on marketable securities 78       78
Net loss (78,254)     (78,254)  
Balances at Dec. 31, 2019 $ 60,081 $ 3 $ 255,142 $ (195,115) $ 51
Balances (in shares) at Dec. 31, 2019   29,084,000